An oral microbiota-based deep neural network model for risk stratification and prognosis prediction in gastric cancer
This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction. Oral microbial markers for GC prognosis and risk stratification were identified from 99 GC patients, and their predictive potential was validated on an external dataset of...
Saved in:
Published in | Journal of oral microbiology Vol. 17; no. 1; p. 2451921 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Taylor & Francis
2025
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
ISSN | 2000-2297 2000-2297 |
DOI | 10.1080/20002297.2025.2451921 |
Cover
Abstract | This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.
Oral microbial markers for GC prognosis and risk stratification were identified from 99 GC patients, and their predictive potential was validated on an external dataset of 111 GC patients. The identified bacterial markers were used to construct a Deep Neural Network (DNN) model, a Random Forest (RF) model, and a Support Vector Machine (SVM) model for predicting GC prognosis.
GC patients with <3 years of survival showed a higher abundance of
and diminished abundances of
and Moryella than those who survived ≥3 years. The Boruta algorithm unearthed Leptotrichia as another significant marker for GC prognosis. Consequently, a DNN model was constructed based on the relative abundances of these bacteria, predicting 3-year and 5-year survival in GC patients with Area Under Curve of 0.814 and 0.912, respectively. Notably, the DNN model outperformed the TNM staging system, SVM and RF models. The prognostic value of these bacterial markers was further reinforced by external validation.
The oral microbiota-based DNN model may advance GC prognosis. The biological functions of these oral bacterial markers warrant further investigation from the perspective of GC progression. |
---|---|
AbstractList | Background This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.Methods Oral microbial markers for GC prognosis and risk stratification were identified from 99 GC patients, and their predictive potential was validated on an external dataset of 111 GC patients. The identified bacterial markers were used to construct a Deep Neural Network (DNN) model, a Random Forest (RF) model, and a Support Vector Machine (SVM) model for predicting GC prognosis.Results GC patients with <3 years of survival showed a higher abundance of Aggregatibacter and diminished abundances of Filifactor and Moryella than those who survived ≥3 years. The Boruta algorithm unearthed Leptotrichia as another significant marker for GC prognosis. Consequently, a DNN model was constructed based on the relative abundances of these bacteria, predicting 3-year and 5-year survival in GC patients with Area Under Curve of 0.814 and 0.912, respectively. Notably, the DNN model outperformed the TNM staging system, SVM and RF models. The prognostic value of these bacterial markers was further reinforced by external validation.Conclusion The oral microbiota-based DNN model may advance GC prognosis. The biological functions of these oral bacterial markers warrant further investigation from the perspective of GC progression. This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.BackgroundThis study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.Oral microbial markers for GC prognosis and risk stratification were identified from 99 GC patients, and their predictive potential was validated on an external dataset of 111 GC patients. The identified bacterial markers were used to construct a Deep Neural Network (DNN) model, a Random Forest (RF) model, and a Support Vector Machine (SVM) model for predicting GC prognosis.MethodsOral microbial markers for GC prognosis and risk stratification were identified from 99 GC patients, and their predictive potential was validated on an external dataset of 111 GC patients. The identified bacterial markers were used to construct a Deep Neural Network (DNN) model, a Random Forest (RF) model, and a Support Vector Machine (SVM) model for predicting GC prognosis.GC patients with <3 years of survival showed a higher abundance of Aggregatibacter and diminished abundances of Filifactor and Moryella than those who survived ≥3 years. The Boruta algorithm unearthed Leptotrichia as another significant marker for GC prognosis. Consequently, a DNN model was constructed based on the relative abundances of these bacteria, predicting 3-year and 5-year survival in GC patients with Area Under Curve of 0.814 and 0.912, respectively. Notably, the DNN model outperformed the TNM staging system, SVM and RF models. The prognostic value of these bacterial markers was further reinforced by external validation.ResultsGC patients with <3 years of survival showed a higher abundance of Aggregatibacter and diminished abundances of Filifactor and Moryella than those who survived ≥3 years. The Boruta algorithm unearthed Leptotrichia as another significant marker for GC prognosis. Consequently, a DNN model was constructed based on the relative abundances of these bacteria, predicting 3-year and 5-year survival in GC patients with Area Under Curve of 0.814 and 0.912, respectively. Notably, the DNN model outperformed the TNM staging system, SVM and RF models. The prognostic value of these bacterial markers was further reinforced by external validation.The oral microbiota-based DNN model may advance GC prognosis. The biological functions of these oral bacterial markers warrant further investigation from the perspective of GC progression.ConclusionThe oral microbiota-based DNN model may advance GC prognosis. The biological functions of these oral bacterial markers warrant further investigation from the perspective of GC progression. This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction. Oral microbial markers for GC prognosis and risk stratification were identified from 99 GC patients, and their predictive potential was validated on an external dataset of 111 GC patients. The identified bacterial markers were used to construct a Deep Neural Network (DNN) model, a Random Forest (RF) model, and a Support Vector Machine (SVM) model for predicting GC prognosis. GC patients with <3 years of survival showed a higher abundance of and diminished abundances of and Moryella than those who survived ≥3 years. The Boruta algorithm unearthed Leptotrichia as another significant marker for GC prognosis. Consequently, a DNN model was constructed based on the relative abundances of these bacteria, predicting 3-year and 5-year survival in GC patients with Area Under Curve of 0.814 and 0.912, respectively. Notably, the DNN model outperformed the TNM staging system, SVM and RF models. The prognostic value of these bacterial markers was further reinforced by external validation. The oral microbiota-based DNN model may advance GC prognosis. The biological functions of these oral bacterial markers warrant further investigation from the perspective of GC progression. |
Author | Yang, Ke-Ren Ren, Rong-Rong Gao, Xue-Feng Zhao, Xiao-Lin Liu, Ying-Qiao Zhang, Can-Gui Wang, Zi-Kai Chen, Ye Mai, Geng-Hui Huang, Kun |
Author_xml | – sequence: 1 givenname: Xue-Feng surname: Gao fullname: Gao, Xue-Feng organization: Integrative Microecology Clinical Center, Shenzhen Clinical Research Center for Digestive Disease, Shenzhen Technology Research Center of Gut Microbiota Transplantation, The Clinical Innovation & Research Center, Shenzhen Key Laboratory of Viral Oncology, Department of Clinical Nutrition, Shenzhen Hospital, Southern Medical University, Shenzhen, China – sequence: 2 givenname: Can-Gui surname: Zhang fullname: Zhang, Can-Gui organization: Integrative Microecology Clinical Center, Shenzhen Clinical Research Center for Digestive Disease, Shenzhen Technology Research Center of Gut Microbiota Transplantation, The Clinical Innovation & Research Center, Shenzhen Key Laboratory of Viral Oncology, Department of Clinical Nutrition, Shenzhen Hospital, Southern Medical University, Shenzhen, China, Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China – sequence: 3 givenname: Kun surname: Huang fullname: Huang, Kun organization: Department of Gastroenterology, Civil Aviation General Hospital, Beijing, China – sequence: 4 givenname: Xiao-Lin surname: Zhao fullname: Zhao, Xiao-Lin organization: Department of Gastroenterology, Civil Aviation General Hospital, Beijing, China – sequence: 5 givenname: Ying-Qiao surname: Liu fullname: Liu, Ying-Qiao organization: Department of Oral and Maxillofacial Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China – sequence: 6 givenname: Zi-Kai surname: Wang fullname: Wang, Zi-Kai organization: Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, China – sequence: 7 givenname: Rong-Rong surname: Ren fullname: Ren, Rong-Rong organization: Department of Gastroenterology and Hepatology, The First Medical Center, Chinese PLA General Hospital, Beijing, China – sequence: 8 givenname: Geng-Hui surname: Mai fullname: Mai, Geng-Hui organization: Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China – sequence: 9 givenname: Ke-Ren surname: Yang fullname: Yang, Ke-Ren organization: Integrative Microecology Clinical Center, Shenzhen Clinical Research Center for Digestive Disease, Shenzhen Technology Research Center of Gut Microbiota Transplantation, The Clinical Innovation & Research Center, Shenzhen Key Laboratory of Viral Oncology, Department of Clinical Nutrition, Shenzhen Hospital, Southern Medical University, Shenzhen, China, Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China – sequence: 10 givenname: Ye surname: Chen fullname: Chen, Ye organization: Integrative Microecology Clinical Center, Shenzhen Clinical Research Center for Digestive Disease, Shenzhen Technology Research Center of Gut Microbiota Transplantation, The Clinical Innovation & Research Center, Shenzhen Key Laboratory of Viral Oncology, Department of Clinical Nutrition, Shenzhen Hospital, Southern Medical University, Shenzhen, China, Department of Gastroenterology, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39840394$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1v1DAQjVARLaU_AeQjlyz-SDa2OKCq4qNSJS5wtsb2eHGb2IudBfHvcXa3VcuFiz0z780bW_NeNicxRWya14yuGJX0HaeUcq6GFae8X_GuZ4qzZ83ZUm8X4ORRfNpclHJbMyq4lB1_0ZwKJTsqVHfW7C4jSRlGMgWbkwlphtZAQUcc4pZE3C1gxPl3yndkSg5H4lMmOZQ7UuYMc_DB1jNFAtGRbU6bmEooNUIX7B4IkWygkoMlFqLF_Kp57mEseHG8z5vvnz5-u_rS3nz9fH11edPabpBzK_1gpWcAyoL3TvFhbaTzKDqOnJs1NdxwDyClkA7B9q5ClCE4MwxWeXHeXB90XYJbvc1hgvxHJwh6X0h5oyHPwY6oQTEqpBIerOokF3U2cMEMKON7uzZV68NBa7szEzqLsf5-fCL6FInhh96kX5qxoVO8E1Xh7VEhp587LLOeQrE4jhAx7YoWrJeM8nXHK_XN42EPU-4XVwn9gVC3VkpG_0BhVC8e0fce0YtH9NEjte_9P302zPv11TeH8T_dfwFiz8Pd |
CitedBy_id | crossref_primary_10_3389_fonc_2025_1524887 |
Cites_doi | 10.1136/gutjnl-2016-312580 10.1136/bmj.l5016 10.1038/s41388-024-02974-w 10.3390/jcm8071079 10.1016/S2589-7500(22)00040-1 10.1016/j.chom.2020.12.001 10.1016/j.micpath.2020.104479 10.1186/1472-6947-8-53 10.1016/j.semcancer.2023.04.009 10.1038/s41587-019-0209-9 10.1002/ijc.33848 10.1038/s41467-022-28437-y 10.1016/j.micpath.2017.11.001 10.1002/mco2.344 10.1099/ijs.0.64705-0 10.1038/s41579-023-00984-1 10.1016/j.cmpb.2022.106924 10.1111/1751-2980.12705 10.1136/gutjnl-2024-332815 10.1186/s13045-023-01451-3 10.3322/caac.21388 10.1038/s41467-020-20260-7 10.3389/fcimb.2021.640309 10.1161/CIRCULATIONAHA.120.047829 10.1016/j.eclinm.2023.101834 10.1186/gb-2011-12-6-r60 10.1016/j.cell.2023.01.035 10.1902/jop.2017.160829 10.1056/NEJMc2306877 10.3322/caac.21660 10.3390/cancers14153742 10.1053/j.gastro.2019.10.019 10.1080/20002297.2017.1368848 10.1177/0272989X06295361 10.1038/s41591-022-01981-2 10.1038/nature13480 10.1016/j.ijbiomac.2022.04.133 10.1126/science.abc4552 10.1016/j.neuron.2020.09.005 10.1016/j.cell.2024.01.004 10.7150/jca.25280 10.1016/j.ebiom.2023.104616 10.1021/acs.chemrev.2c00431 10.1136/gutjnl-2017-314281 10.1093/jnci/95.9.634 10.1038/s41591-019-0377-7 10.1038/s41392-022-00974-4 10.3389/fcimb.2018.00433 10.1016/S2468-1253(19)30328-0 10.1016/S1470-2045(18)30131-1 10.1504/IJCISTUDIES.2021.113826 10.1016/j.ebiom.2018.12.028 |
ContentType | Journal Article |
Copyright | 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2025 The Author(s) |
Copyright_xml | – notice: 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. – notice: 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2025 The Author(s) |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1080/20002297.2025.2451921 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Dentistry |
DocumentTitleAlternate | X.-F. GAO ET AL |
EISSN | 2000-2297 |
ExternalDocumentID | oai_doaj_org_article_a9103893fac948238f7a231ba9bf5c6b PMC11749243 39840394 10_1080_20002297_2025_2451921 |
Genre | Journal Article |
GroupedDBID | 0YH 34H 5VS 7X7 8FE 8FH 8FI 8FJ AAYXX ABDBF ABUWG ACGFS ACUHS ADBBV AEUYN AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CCPQU CITATION DIK E3Z EAP EBD EBS ESX FRP FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK KQ8 LK8 M7P MM. M~E O5R O5S OK1 PHGZM PHGZT PIMPY PQQKQ PROAC RPM TDBHL TFW TUS UKHRP 3V. 8WT ADRAZ EAD EJD H13 HYE IPNFZ M48 M4Z NPM RIG 7X8 PQGLB PUEGO 5PM |
ID | FETCH-LOGICAL-c478t-8f7c8f1aa9caffd9276b8dfe342e22b60b2b2faa8838deac5de3401eadb77c9f3 |
IEDL.DBID | M48 |
ISSN | 2000-2297 |
IngestDate | Wed Aug 27 00:53:27 EDT 2025 Thu Aug 21 18:41:20 EDT 2025 Thu Sep 04 19:10:32 EDT 2025 Thu Jan 30 12:28:10 EST 2025 Tue Jul 01 00:59:35 EDT 2025 Thu Apr 24 22:57:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | risk stratification oral microbiota Gastric cancer prognosis deep neural network |
Language | English |
License | 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c478t-8f7c8f1aa9caffd9276b8dfe342e22b60b2b2faa8838deac5de3401eadb77c9f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Co-first authors with equal contribution. |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1080/20002297.2025.2451921 |
PMID | 39840394 |
PQID | 3158102642 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_a9103893fac948238f7a231ba9bf5c6b pubmedcentral_primary_oai_pubmedcentral_nih_gov_11749243 proquest_miscellaneous_3158102642 pubmed_primary_39840394 crossref_primary_10_1080_20002297_2025_2451921 crossref_citationtrail_10_1080_20002297_2025_2451921 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-00-00 |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – year: 2025 text: 2025-00-00 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of oral microbiology |
PublicationTitleAlternate | J Oral Microbiol |
PublicationYear | 2025 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_8_49_1 e_1_3_8_28_1 e_1_3_8_47_1 e_1_3_8_26_1 e_1_3_8_22_1 e_1_3_8_45_1 e_1_3_8_24_1 e_1_3_8_43_1 e_1_3_8_41_1 e_1_3_8_20_1 e_1_3_8_18_1 e_1_3_8_14_1 e_1_3_8_39_1 e_1_3_8_16_1 e_1_3_8_37_1 e_1_3_8_8_1 e_1_3_8_6_1 e_1_3_8_2_1 e_1_3_8_10_1 e_1_3_8_35_1 e_1_3_8_12_1 e_1_3_8_33_1 e_1_3_8_31_1 e_1_3_8_52_1 e_1_3_8_50_1 e_1_3_8_29_1 e_1_3_8_27_1 e_1_3_8_25_1 e_1_3_8_48_1 e_1_3_8_21_1 e_1_3_8_46_1 e_1_3_8_23_1 e_1_3_8_44_1 e_1_3_8_42_1 e_1_3_8_40_1 e_1_3_8_19_1 e_1_3_8_15_1 e_1_3_8_38_1 e_1_3_8_17_1 e_1_3_8_36_1 Usui Y (e_1_3_8_4_1) 2023; 389 e_1_3_8_9_1 e_1_3_8_7_1 e_1_3_8_5_1 e_1_3_8_3_1 e_1_3_8_11_1 e_1_3_8_34_1 e_1_3_8_13_1 e_1_3_8_32_1 e_1_3_8_30_1 e_1_3_8_53_1 e_1_3_8_51_1 |
References_xml | – ident: e_1_3_8_42_1 doi: 10.1136/gutjnl-2016-312580 – ident: e_1_3_8_6_1 doi: 10.1136/bmj.l5016 – ident: e_1_3_8_31_1 doi: 10.1038/s41388-024-02974-w – ident: e_1_3_8_38_1 doi: 10.3390/jcm8071079 – ident: e_1_3_8_48_1 doi: 10.1016/S2589-7500(22)00040-1 – ident: e_1_3_8_30_1 doi: 10.1016/j.chom.2020.12.001 – ident: e_1_3_8_44_1 doi: 10.1016/j.micpath.2020.104479 – ident: e_1_3_8_34_1 doi: 10.1186/1472-6947-8-53 – ident: e_1_3_8_19_1 doi: 10.1016/j.semcancer.2023.04.009 – ident: e_1_3_8_27_1 doi: 10.1038/s41587-019-0209-9 – ident: e_1_3_8_15_1 doi: 10.1002/ijc.33848 – ident: e_1_3_8_50_1 doi: 10.1038/s41467-022-28437-y – ident: e_1_3_8_39_1 doi: 10.1016/j.micpath.2017.11.001 – ident: e_1_3_8_45_1 doi: 10.1002/mco2.344 – ident: e_1_3_8_46_1 doi: 10.1099/ijs.0.64705-0 – ident: e_1_3_8_24_1 doi: 10.1038/s41579-023-00984-1 – ident: e_1_3_8_51_1 doi: 10.1016/j.cmpb.2022.106924 – ident: e_1_3_8_26_1 doi: 10.1111/1751-2980.12705 – ident: e_1_3_8_37_1 doi: 10.1136/gutjnl-2024-332815 – ident: e_1_3_8_10_1 doi: 10.1186/s13045-023-01451-3 – ident: e_1_3_8_8_1 doi: 10.3322/caac.21388 – ident: e_1_3_8_49_1 doi: 10.1038/s41467-020-20260-7 – ident: e_1_3_8_18_1 doi: 10.3389/fcimb.2021.640309 – ident: e_1_3_8_23_1 doi: 10.1161/CIRCULATIONAHA.120.047829 – ident: e_1_3_8_25_1 doi: 10.1016/j.eclinm.2023.101834 – ident: e_1_3_8_28_1 doi: 10.1186/gb-2011-12-6-r60 – ident: e_1_3_8_21_1 doi: 10.1016/j.cell.2023.01.035 – ident: e_1_3_8_41_1 doi: 10.1902/jop.2017.160829 – volume: 389 start-page: 379 issue: 4 year: 2023 ident: e_1_3_8_4_1 article-title: Helicobacter pylori, homologous-recombination genes, and gastric cancer. Reply publication-title: N Engl J Med doi: 10.1056/NEJMc2306877 – ident: e_1_3_8_2_1 doi: 10.3322/caac.21660 – ident: e_1_3_8_52_1 doi: 10.3390/cancers14153742 – ident: e_1_3_8_7_1 doi: 10.1053/j.gastro.2019.10.019 – ident: e_1_3_8_43_1 doi: 10.1080/20002297.2017.1368848 – ident: e_1_3_8_33_1 doi: 10.1177/0272989X06295361 – ident: e_1_3_8_20_1 doi: 10.1038/s41591-022-01981-2 – ident: e_1_3_8_47_1 doi: 10.1038/nature13480 – ident: e_1_3_8_16_1 doi: 10.1016/j.ijbiomac.2022.04.133 – ident: e_1_3_8_14_1 doi: 10.1126/science.abc4552 – ident: e_1_3_8_22_1 doi: 10.1016/j.neuron.2020.09.005 – ident: e_1_3_8_35_1 doi: 10.1016/j.cell.2024.01.004 – ident: e_1_3_8_36_1 doi: 10.7150/jca.25280 – ident: e_1_3_8_5_1 doi: 10.1016/j.ebiom.2023.104616 – ident: e_1_3_8_11_1 doi: 10.1021/acs.chemrev.2c00431 – ident: e_1_3_8_17_1 doi: 10.1136/gutjnl-2017-314281 – ident: e_1_3_8_32_1 doi: 10.1093/jnci/95.9.634 – ident: e_1_3_8_13_1 doi: 10.1038/s41591-019-0377-7 – ident: e_1_3_8_12_1 doi: 10.1038/s41392-022-00974-4 – ident: e_1_3_8_40_1 doi: 10.3389/fcimb.2018.00433 – ident: e_1_3_8_3_1 doi: 10.1016/S2468-1253(19)30328-0 – ident: e_1_3_8_9_1 doi: 10.1016/S1470-2045(18)30131-1 – ident: e_1_3_8_29_1 doi: 10.1504/IJCISTUDIES.2021.113826 – ident: e_1_3_8_53_1 doi: 10.1016/j.ebiom.2018.12.028 |
SSID | ssj0000328842 |
Score | 2.3409305 |
Snippet | This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.
Oral microbial markers for GC... This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.BackgroundThis study aims to... Background This study aims to develop an oral microbiota-based model for gastric cancer (GC) risk stratification and prognosis prediction.Methods Oral... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2451921 |
SubjectTerms | deep neural network Gastric cancer oral microbiota prognosis risk stratification |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhUJJLaZI-tm2KArk6sfWwpWPaNIRCe0ogN6PXpAutNmR3D_n3nbG8y24p5NKbsSwsz3yWZqSZbxg71TFF66CrGoC2UsqnyihXV02gzMY6SQOUjfz9R3t9q77d6buNUl8UE1bogYvgzp0lCm8rwQWrDC4w0Dm0SbyzHnRoPc2-ta03nKlhDpbCGCVWKTumPhcD1Yvt0CUU-kwQq4pothajgbP_X4bm3_GSGwvQ1Sv2crQc-UUZ8QHbSfmQvSi1JJ8O2d4lxf1Q6bYjtrzInDLv-e9p4VlauIqWq8hjSg-cOCyxMZcIcD4Uw-FovHKKM-eFSBfGvTzucuQUxJVn8-kcr-hgZ2iYZn7vqOpH4IGg8_ia3V59vflyXY31FaqgOrOoUJTBQOOcDQ4gWtG13kRIUokkhG9rL7wA54yRJuIEjXqV6I4h9nzXBQvyDdvNs5zeMW4gmRSdBgHo76FytHBobEStwZpGiQlTK0H3YSQfpxoYv_pm5Chd6acn_fSjfibsbN3tobBvPNfhM2lx_TCRZw83EFL9CKn-OUhN2MkKAz3-bHSC4nKaLee9bLRBi6ylD3pbMLF-lbToK0urJsxsoWVrLNstefpzIPRu0C1EP1i-_x-j_8D2SSJlm-gj2108LtMxGk4L_2n4R_4AICEWIQ priority: 102 providerName: Directory of Open Access Journals |
Title | An oral microbiota-based deep neural network model for risk stratification and prognosis prediction in gastric cancer |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39840394 https://www.proquest.com/docview/3158102642 https://pubmed.ncbi.nlm.nih.gov/PMC11749243 https://doaj.org/article/a9103893fac948238f7a231ba9bf5c6b |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEA-1ReyLaP06P44Ivu55m2Q3yYNIq61FaBHx4N6WfNaDmmvvA-x_78xu9vCkIviyLJsNm81Mkt8kM78h5E3lg9cmyqKMsS6EsKFQwoyL0mFk4zhwFTEa-ey8Pp2Iz9NqukN6QoXcgctbTTvMJzVZXI5-Xt-8hwH_LnvIvWUti4uWYO2xasSQMAVDy_dgcarRHjvLiL-dnDlTSrA-ludvtbdWqZbM_zYE-qcj5W8r08kDcj9DSnrY6cBDshPSAbnbJZm8OSD3PqJDEOZ0e0TWh4liSD79MesImFamwHXMUx_CFUVySyhMnWs4bbPkUEC1FB3QacewG_MmHzXJU_TuSvPlbAl3eOLTFswSvTCYDsRRhzq1eEwmJ8ffPpwWOfFC4YRUq0JF6VQsjdHOxOg1k7VVPgYuWGDM1mPLLIvGKMWVh5kbBM7BTgOltFI6HfkTspvmKTwjVMWggjdVZBEMQWt0xQygEF9VUatSsAERfUc3LrOSY3KMy6bM5KW9fBqUT5PlMyCjTbWrjpbjXxWOUIqbl5FVu30wX1w0eZA2RiNdvObROC0UgJkoDeBfaLWNlavtgLzudaCBUYhHKyaF-XrZ8LJSANVq_KGnnU5sPsU1GNFciwFRW9qy1ZbtkjT73jJ9l2AvgoHMn_9_1RdkH_uh2zV6SXZXi3V4BThqZYfkjpzKIdk7Oj7_8nXY7kbA9dO0HLZj5hcneCFA |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+oral+microbiota-based+deep+neural+network+model+for+risk+stratification+and+prognosis+prediction+in+gastric+cancer&rft.jtitle=Journal+of+oral+microbiology&rft.au=Gao%2C+Xue-Feng&rft.au=Zhang%2C+Can-Gui&rft.au=Huang%2C+Kun&rft.au=Zhao%2C+Xiao-Lin&rft.date=2025&rft.pub=Taylor+%26+Francis&rft.eissn=2000-2297&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1080%2F20002297.2025.2451921&rft.externalDocID=PMC11749243 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2000-2297&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2000-2297&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2000-2297&client=summon |